1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Chromosome 2q31.2 Deletion Syndrome: new trials by email Literature Review of Chromosome 2q31.2 Deletion Syndrome trials Research Report on Chromosome 2q31.2 Deletion Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type celiprolol, Control - EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT, CHROMOSOME 2q31.2 DELETION SYNDROME | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 54 | 2003-10-01 | 2013-01-16 |
Cardiovascular Diseases (1) · Ehlers-Danlos Syndrome (1) · Ehlers-Danlos Syndrome, Type IV (1)
Aneurysm (1) · Aortic Dissection (1) · Collagen Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Dissection, Blood Vessel (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Skin Abnormalities (1) · Skin Diseases (1) · Skin Diseases, Genetic (1)
Celiprolol (1)
Assistance Publique - Hôpitaux de Paris (1)